94-24943. Termination of Temporary Deferment of Activities Relating to Biologics Submissions and Notice of New Mailing Address; Correction

[Federal Register Volume 59, Number 195 (Tuesday, October 11, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-24943]


[[Page Unknown]]

[Federal Register: October 11, 1994]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES
 

Termination of Temporary Deferment of Activities Relating to 
Biologics Submissions and Notice of New Mailing Address; Correction

AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of September 23, 1994 (59 FR 
48895). The document announced the termination of temporary deferment 
of activities relating to biologics submissions and the new mailing 
addresses for submissions. The document was published with a 
typographical error. This document corrects that error.
FOR FURTHER INFORMATION CONTACT: Mark A. Elengold, Center for Biologics 
Evaluation Research (HFM-11), Food and Drug Administration, 1401 
Rockville Pike, Rockville, MD 20852-1448, 301-594-2000.
    In FR Doc. 94-23617, appearing on page 48895 in the Federal 
Register of September 23, 1994, the following correction is made: On 
the same page, in the second column, in the last paragraph, in the 
fourth line from the bottom ``549-5656'' is corrected the read ``594-
5656''.

    Dated: October 3, 1994.
William K. Hubbard,
Interim Deputy Commissioner for Policy.
[FR Doc. 94-24943 Filed 10-7-94; 8:45 am]
BILLING CODE 4160-01-F